U.S., Aug. 30 -- ClinicalTrials.gov registry received information related to the study (NCT07147218) titled 'Accelerated TMS for MDD' on Aug. 27.
Brief Summary: An open-label, multi-center, prospective study to evaluate feasibility and efficacy of accelerated TMS for patients with Major Depressive Disorder (MDD).
Study Start Date: Aug. 21
Study Type: INTERVENTIONAL
Condition:
Major Depressive Disorder
Intervention:
DEVICE: TMS
transcranial magnetic stimulation - DASH 36 treatment delivered in 5 days
Recruitment Status: RECRUITING
Sponsor: Neuronetics
Published by HT Digital Content Services with permission from Health Daily Digest....